Immunocore Holdings plc
IMCR
$28.27
-$0.26-0.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 12.97M | -30.06M | -177.00K | -10.30M | 5.02M |
| Total Depreciation and Amortization | 948.00K | 834.00K | 798.00K | 780.00K | 854.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.20M | 23.67M | -3.75M | 8.75M | 2.17M |
| Change in Net Operating Assets | -29.89M | -27.10M | -1.32M | 26.74M | -7.61M |
| Cash from Operations | -13.78M | -32.66M | -4.46M | 25.96M | 435.00K |
| Capital Expenditure | -1.78M | -2.88M | -748.00K | -414.00K | -298.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.00M | 2.00M | 6.00M | -30.00M | 10.00M |
| Cash from Investing | 4.22M | -880.00K | 5.25M | -30.41M | 9.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 656.00K | 4.28M | 1.87M | 3.67M | 2.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 656.00K | 4.28M | 1.87M | 3.67M | 2.55M |
| Foreign Exchange rate Adjustments | -6.13M | -1.45M | 7.82M | 11.87M | 8.43M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.03M | -30.70M | 10.48M | 11.09M | 21.11M |